Voyager Technologies (VOYG) shares more than doubled Wednesday in their debut on the New York Stock Exchange after the initial public offering of 12.3 million class A shares priced at $31 apiece.
More than 10.8 million shares of the company traded intraday.
Kazia Therapeutics (KZIA) said Wednesday that preclinical data on paxalisib showed the drug's potential to reprogram the tumor microenvironment and improve immune response in triple-negative breast cancer.
Shares soared 78% as intraday trading volume soared to over 43.4 million from a daily average of roughly 29,000.
Ouster (OUST) said Wednesday that the US Department of Defense has vetted and approved the company's OS1 digital lidar for use in unmanned aerial systems.
Shares advanced 29% as intraday trading volume climbed to more than 13.4 million from a daily average of about 1.6 million.
Price: 63.00, Change: +32.00, Percent Change: +103.23
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。